Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cross Infection | 32 | 2023 | 1416 | 4.440 |
Why?
|
Hospitals, Community | 10 | 2020 | 348 | 2.330 |
Why?
|
Anti-Bacterial Agents | 28 | 2024 | 7181 | 1.920 |
Why?
|
Mupirocin | 9 | 2023 | 56 | 1.890 |
Why?
|
Chlorhexidine | 10 | 2023 | 162 | 1.710 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 18 | 2023 | 687 | 1.680 |
Why?
|
Sepsis | 14 | 2024 | 2593 | 1.640 |
Why?
|
Catheter-Related Infections | 4 | 2023 | 252 | 1.370 |
Why?
|
Infection Control | 18 | 2022 | 966 | 1.330 |
Why?
|
Anti-Infective Agents | 11 | 2023 | 972 | 1.310 |
Why?
|
Staphylococcal Infections | 17 | 2023 | 1400 | 1.220 |
Why?
|
Anti-Infective Agents, Local | 7 | 2023 | 250 | 1.100 |
Why?
|
Pneumonia, Ventilator-Associated | 9 | 2022 | 274 | 1.050 |
Why?
|
Baths | 5 | 2023 | 54 | 1.050 |
Why?
|
Bacteremia | 7 | 2022 | 962 | 0.980 |
Why?
|
Intensive Care Units | 15 | 2023 | 3679 | 0.980 |
Why?
|
Carrier State | 8 | 2019 | 518 | 0.920 |
Why?
|
Drug Resistance, Microbial | 4 | 2019 | 862 | 0.850 |
Why?
|
Urinary Tract Infections | 4 | 2023 | 788 | 0.830 |
Why?
|
Drug Resistance, Bacterial | 8 | 2020 | 1035 | 0.770 |
Why?
|
Bacterial Infections | 9 | 2019 | 1401 | 0.680 |
Why?
|
Carbapenems | 2 | 2018 | 118 | 0.670 |
Why?
|
Pharmacists | 5 | 2020 | 248 | 0.650 |
Why?
|
Nasal Mucosa | 2 | 2019 | 373 | 0.580 |
Why?
|
Drug Utilization | 3 | 2018 | 1183 | 0.540 |
Why?
|
Mandatory Reporting | 1 | 2017 | 121 | 0.540 |
Why?
|
Surgical Wound Infection | 6 | 2023 | 1540 | 0.490 |
Why?
|
Immunization Programs | 5 | 2013 | 260 | 0.470 |
Why?
|
Disinfectants | 1 | 2014 | 116 | 0.450 |
Why?
|
Fungi | 1 | 2016 | 327 | 0.450 |
Why?
|
Proton Pump Inhibitors | 1 | 2018 | 526 | 0.450 |
Why?
|
Shock, Septic | 4 | 2024 | 775 | 0.440 |
Why?
|
Drug Utilization Review | 4 | 2016 | 245 | 0.440 |
Why?
|
Cooperative Behavior | 5 | 2018 | 1504 | 0.430 |
Why?
|
Monitoring, Physiologic | 1 | 2020 | 1738 | 0.420 |
Why?
|
Hospitals | 12 | 2023 | 3952 | 0.420 |
Why?
|
Disinfection | 5 | 2019 | 191 | 0.390 |
Why?
|
Clostridium Infections | 1 | 2018 | 548 | 0.390 |
Why?
|
Infectious Disease Transmission, Professional-to-Patient | 1 | 2011 | 35 | 0.390 |
Why?
|
Disease Transmission, Infectious | 3 | 2019 | 547 | 0.370 |
Why?
|
Influenza, Human | 7 | 2013 | 1479 | 0.370 |
Why?
|
Societies | 1 | 2010 | 104 | 0.360 |
Why?
|
Pharmacy Service, Hospital | 1 | 2009 | 133 | 0.310 |
Why?
|
Population Surveillance | 5 | 2020 | 2616 | 0.300 |
Why?
|
United States | 43 | 2024 | 69872 | 0.300 |
Why?
|
Bacteria | 2 | 2016 | 2114 | 0.300 |
Why?
|
Health Personnel | 5 | 2012 | 3218 | 0.290 |
Why?
|
Digestive System Surgical Procedures | 2 | 2023 | 576 | 0.280 |
Why?
|
Administration, Intranasal | 5 | 2023 | 446 | 0.280 |
Why?
|
Community-Acquired Infections | 2 | 2017 | 465 | 0.280 |
Why?
|
Vaccination | 4 | 2011 | 3278 | 0.280 |
Why?
|
Respiration, Artificial | 6 | 2013 | 2569 | 0.270 |
Why?
|
Communicable Diseases | 4 | 2023 | 880 | 0.270 |
Why?
|
Drug Resistance, Multiple, Bacterial | 3 | 2020 | 567 | 0.270 |
Why?
|
Humans | 112 | 2024 | 744343 | 0.260 |
Why?
|
Drug and Narcotic Control | 2 | 2016 | 146 | 0.250 |
Why?
|
Administration, Topical | 2 | 2016 | 690 | 0.240 |
Why?
|
Iodophors | 1 | 2023 | 7 | 0.240 |
Why?
|
Influenza Vaccines | 4 | 2012 | 738 | 0.220 |
Why?
|
Candidiasis, Invasive | 1 | 2022 | 22 | 0.220 |
Why?
|
Quality Indicators, Health Care | 4 | 2021 | 1831 | 0.210 |
Why?
|
Ventilator-Induced Lung Injury | 2 | 2013 | 122 | 0.210 |
Why?
|
Practice Guidelines as Topic | 6 | 2019 | 7279 | 0.210 |
Why?
|
Mandatory Programs | 3 | 2011 | 87 | 0.200 |
Why?
|
Research Design | 5 | 2019 | 5987 | 0.190 |
Why?
|
Infection Control Practitioners | 2 | 2018 | 12 | 0.190 |
Why?
|
Antibiotic Prophylaxis | 2 | 2015 | 639 | 0.180 |
Why?
|
Streptococcus agalactiae | 2 | 1992 | 375 | 0.180 |
Why?
|
Delivery of Health Care | 8 | 2023 | 5319 | 0.180 |
Why?
|
Influenza A virus | 2 | 2013 | 456 | 0.170 |
Why?
|
Infectious Disease Medicine | 3 | 2016 | 46 | 0.170 |
Why?
|
Cellulitis | 3 | 1990 | 206 | 0.160 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2020 | 232 | 0.160 |
Why?
|
Streptococcal Infections | 3 | 1992 | 638 | 0.160 |
Why?
|
Staphylococcus aureus | 6 | 2023 | 1451 | 0.160 |
Why?
|
Nasal Cavity | 3 | 2014 | 313 | 0.160 |
Why?
|
Candidiasis | 2 | 2022 | 366 | 0.150 |
Why?
|
Personnel, Hospital | 2 | 2013 | 283 | 0.150 |
Why?
|
Medicare | 4 | 2024 | 6566 | 0.150 |
Why?
|
Electronic Health Records | 3 | 2019 | 4468 | 0.150 |
Why?
|
Calcitonin | 1 | 2018 | 336 | 0.140 |
Why?
|
Epidemiology | 3 | 2016 | 287 | 0.140 |
Why?
|
Multiple Organ Failure | 1 | 2019 | 390 | 0.140 |
Why?
|
Inservice Training | 1 | 2018 | 392 | 0.130 |
Why?
|
Nose | 2 | 2016 | 509 | 0.130 |
Why?
|
Tracheoesophageal Fistula | 1 | 1996 | 129 | 0.120 |
Why?
|
Algorithms | 5 | 2013 | 13881 | 0.120 |
Why?
|
Ventilators, Mechanical | 2 | 2013 | 292 | 0.120 |
Why?
|
Emergency Service, Hospital | 3 | 2023 | 7659 | 0.110 |
Why?
|
Evidence-Based Medicine | 2 | 2019 | 3610 | 0.110 |
Why?
|
Pseudomonas Infections | 3 | 2015 | 613 | 0.110 |
Why?
|
Hospitalization | 4 | 2021 | 10262 | 0.110 |
Why?
|
Pandemics | 5 | 2023 | 8388 | 0.110 |
Why?
|
Influenza B virus | 1 | 2012 | 50 | 0.110 |
Why?
|
Wound Infection | 3 | 1992 | 242 | 0.110 |
Why?
|
Hospitals, Urban | 1 | 2014 | 499 | 0.110 |
Why?
|
Retrospective Studies | 12 | 2023 | 77449 | 0.100 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 1996 | 657 | 0.100 |
Why?
|
Mycobacterium Infections | 2 | 2003 | 119 | 0.100 |
Why?
|
Cerebrospinal Fluid Rhinorrhea | 1 | 1992 | 80 | 0.100 |
Why?
|
Escherichia coli Infections | 1 | 2015 | 532 | 0.100 |
Why?
|
Health Services Research | 2 | 2019 | 1836 | 0.100 |
Why?
|
Professional Role | 2 | 2018 | 306 | 0.100 |
Why?
|
Cytomegalovirus | 1 | 1996 | 732 | 0.100 |
Why?
|
Health Care Surveys | 3 | 2014 | 2453 | 0.100 |
Why?
|
Osteomyelitis | 2 | 1990 | 402 | 0.100 |
Why?
|
Biomedical Research | 2 | 2017 | 3309 | 0.090 |
Why?
|
Female | 27 | 2023 | 380194 | 0.090 |
Why?
|
Male | 34 | 2023 | 350118 | 0.090 |
Why?
|
Specialization | 2 | 2018 | 777 | 0.090 |
Why?
|
Drug Therapy, Combination | 2 | 2018 | 6489 | 0.090 |
Why?
|
Aged | 23 | 2024 | 163280 | 0.090 |
Why?
|
Pasteurella Infections | 1 | 1989 | 8 | 0.090 |
Why?
|
Meningitis, Bacterial | 1 | 1992 | 218 | 0.090 |
Why?
|
Vibrio Infections | 1 | 1990 | 33 | 0.090 |
Why?
|
Public Health | 4 | 2023 | 2603 | 0.090 |
Why?
|
Health Planning Guidelines | 1 | 2010 | 163 | 0.090 |
Why?
|
Gastrointestinal Tract | 1 | 2016 | 814 | 0.090 |
Why?
|
Middle Aged | 28 | 2023 | 213383 | 0.090 |
Why?
|
Patient Discharge | 1 | 2022 | 3313 | 0.090 |
Why?
|
Odds Ratio | 2 | 2021 | 9849 | 0.090 |
Why?
|
Adult | 31 | 2024 | 214055 | 0.090 |
Why?
|
Cytomegalovirus Infections | 1 | 1996 | 820 | 0.090 |
Why?
|
beta-Lactamases | 2 | 2009 | 306 | 0.090 |
Why?
|
Fluoroquinolones | 2 | 2015 | 310 | 0.090 |
Why?
|
Information Dissemination | 1 | 2017 | 1099 | 0.080 |
Why?
|
Cost Savings | 1 | 2014 | 926 | 0.080 |
Why?
|
Bursitis | 1 | 1989 | 83 | 0.080 |
Why?
|
Leadership | 1 | 2018 | 1357 | 0.080 |
Why?
|
Comparative Effectiveness Research | 2 | 2013 | 681 | 0.080 |
Why?
|
Mycoses | 1 | 2012 | 376 | 0.080 |
Why?
|
Tricuspid Valve | 1 | 1991 | 403 | 0.080 |
Why?
|
Pneumonia | 6 | 2017 | 2133 | 0.080 |
Why?
|
Drug Resistance, Multiple | 1 | 2009 | 252 | 0.080 |
Why?
|
Enterobacteriaceae Infections | 1 | 1990 | 187 | 0.080 |
Why?
|
Communicable Disease Control | 3 | 2023 | 857 | 0.080 |
Why?
|
Medical Informatics | 1 | 2014 | 745 | 0.080 |
Why?
|
Endocarditis, Bacterial | 1 | 1991 | 455 | 0.070 |
Why?
|
Seasons | 1 | 2013 | 1493 | 0.070 |
Why?
|
Hospital Mortality | 4 | 2023 | 5317 | 0.070 |
Why?
|
Endophthalmitis | 1 | 1989 | 262 | 0.070 |
Why?
|
Vancomycin | 3 | 2015 | 501 | 0.070 |
Why?
|
Patient Protection and Affordable Care Act | 1 | 2017 | 1209 | 0.070 |
Why?
|
Program Development | 1 | 2013 | 1316 | 0.070 |
Why?
|
Kidney Failure, Chronic | 1 | 2019 | 2538 | 0.070 |
Why?
|
Physicians | 2 | 2018 | 4567 | 0.070 |
Why?
|
Urban Population | 1 | 2014 | 2021 | 0.070 |
Why?
|
Abscess | 1 | 1990 | 607 | 0.070 |
Why?
|
Safety | 1 | 2011 | 1186 | 0.070 |
Why?
|
Research | 1 | 2014 | 1999 | 0.070 |
Why?
|
Software | 1 | 2020 | 4443 | 0.070 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2018 | 10943 | 0.070 |
Why?
|
Ofloxacin | 1 | 2005 | 65 | 0.070 |
Why?
|
Virus Diseases | 1 | 2012 | 711 | 0.070 |
Why?
|
Abortion, Induced | 1 | 1991 | 458 | 0.070 |
Why?
|
Mycobacterium tuberculosis | 1 | 1996 | 1832 | 0.060 |
Why?
|
Health Resources | 1 | 2011 | 911 | 0.060 |
Why?
|
Treatment Refusal | 1 | 2008 | 421 | 0.060 |
Why?
|
Prescription Drugs | 1 | 2012 | 595 | 0.060 |
Why?
|
Tuberculosis | 2 | 1996 | 1912 | 0.060 |
Why?
|
Ceftriaxone | 1 | 2005 | 168 | 0.060 |
Why?
|
Diagnosis, Differential | 3 | 2018 | 12959 | 0.060 |
Why?
|
Opioid-Related Disorders | 1 | 2019 | 2065 | 0.060 |
Why?
|
Congresses as Topic | 1 | 2008 | 764 | 0.060 |
Why?
|
Ciprofloxacin | 1 | 2005 | 315 | 0.060 |
Why?
|
Health Policy | 3 | 2013 | 2661 | 0.060 |
Why?
|
Clinical Trials as Topic | 2 | 2017 | 7913 | 0.060 |
Why?
|
Echinocandins | 1 | 2022 | 45 | 0.050 |
Why?
|
Community Health Centers | 1 | 2006 | 430 | 0.050 |
Why?
|
Emergency Medical Services | 1 | 2014 | 1917 | 0.050 |
Why?
|
National Institutes of Health (U.S.) | 2 | 2017 | 780 | 0.050 |
Why?
|
Skin | 1 | 2016 | 4364 | 0.050 |
Why?
|
Mycobacterium bovis | 1 | 2003 | 150 | 0.050 |
Why?
|
Water Microbiology | 1 | 2002 | 117 | 0.050 |
Why?
|
Tampons, Surgical | 1 | 1981 | 10 | 0.050 |
Why?
|
Oils, Volatile | 1 | 2021 | 13 | 0.050 |
Why?
|
Nasal Sprays | 1 | 2021 | 18 | 0.050 |
Why?
|
Quality Assurance, Health Care | 2 | 2009 | 2212 | 0.050 |
Why?
|
Carrageenan | 1 | 2021 | 67 | 0.050 |
Why?
|
Water Supply | 1 | 2002 | 214 | 0.050 |
Why?
|
Mycobacterium | 1 | 2002 | 249 | 0.050 |
Why?
|
Terpenes | 1 | 2021 | 98 | 0.050 |
Why?
|
Povidone-Iodine | 1 | 2021 | 59 | 0.050 |
Why?
|
Young Adult | 5 | 2019 | 56430 | 0.050 |
Why?
|
Salicylates | 1 | 2021 | 126 | 0.050 |
Why?
|
Hypoglycemia | 2 | 2005 | 861 | 0.050 |
Why?
|
Respiratory Tract Infections | 2 | 2019 | 961 | 0.050 |
Why?
|
Cohort Studies | 3 | 2021 | 40561 | 0.040 |
Why?
|
BCG Vaccine | 1 | 2003 | 369 | 0.040 |
Why?
|
Aged, 80 and over | 7 | 2023 | 57776 | 0.040 |
Why?
|
Colorectal Neoplasms | 1 | 2019 | 6773 | 0.040 |
Why?
|
Program Evaluation | 2 | 2019 | 2488 | 0.040 |
Why?
|
Texas | 2 | 2014 | 392 | 0.040 |
Why?
|
Infant, Newborn | 4 | 2022 | 25625 | 0.040 |
Why?
|
Hygiene | 1 | 2019 | 98 | 0.040 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2024 | 612 | 0.040 |
Why?
|
Reimbursement, Incentive | 1 | 2024 | 540 | 0.040 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2020 | 214 | 0.040 |
Why?
|
Antifungal Agents | 1 | 2022 | 730 | 0.040 |
Why?
|
Nocardia Infections | 3 | 1982 | 18 | 0.040 |
Why?
|
Penicillins | 2 | 2015 | 380 | 0.040 |
Why?
|
Drug Combinations | 3 | 2021 | 1959 | 0.040 |
Why?
|
Hydrogen Peroxide | 1 | 2021 | 731 | 0.040 |
Why?
|
Inappropriate Prescribing | 1 | 2019 | 202 | 0.040 |
Why?
|
Staphylococcal Skin Infections | 1 | 2017 | 75 | 0.040 |
Why?
|
Insurance Claim Reporting | 1 | 2017 | 163 | 0.040 |
Why?
|
Health Facilities | 1 | 2022 | 573 | 0.040 |
Why?
|
Risk Assessment | 2 | 2015 | 23338 | 0.040 |
Why?
|
Hyperglycemia | 1 | 2005 | 1373 | 0.040 |
Why?
|
Patients | 1 | 2023 | 900 | 0.040 |
Why?
|
Health Plan Implementation | 1 | 2019 | 352 | 0.030 |
Why?
|
Clinical Coding | 1 | 2017 | 171 | 0.030 |
Why?
|
Treatment Outcome | 3 | 2019 | 63114 | 0.030 |
Why?
|
Medical Audit | 1 | 2017 | 467 | 0.030 |
Why?
|
Exanthema | 1 | 1981 | 501 | 0.030 |
Why?
|
Soft Tissue Infections | 1 | 2017 | 155 | 0.030 |
Why?
|
Cefuroxime | 1 | 2015 | 23 | 0.030 |
Why?
|
Bacterial Proteins | 1 | 2009 | 3848 | 0.030 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2019 | 397 | 0.030 |
Why?
|
Health Care Costs | 1 | 2009 | 3209 | 0.030 |
Why?
|
Bacteriuria | 1 | 2015 | 102 | 0.030 |
Why?
|
Candida | 1 | 2015 | 172 | 0.030 |
Why?
|
Microbial Sensitivity Tests | 3 | 2016 | 1877 | 0.030 |
Why?
|
Cefazolin | 1 | 2015 | 96 | 0.030 |
Why?
|
Child | 7 | 2023 | 77709 | 0.030 |
Why?
|
Research Report | 1 | 2017 | 355 | 0.030 |
Why?
|
Ethics Committees, Research | 1 | 2015 | 194 | 0.030 |
Why?
|
Housekeeping, Hospital | 1 | 2013 | 17 | 0.030 |
Why?
|
Multi-Institutional Systems | 1 | 2013 | 43 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2010 | 9959 | 0.030 |
Why?
|
Societies, Medical | 2 | 2018 | 3743 | 0.030 |
Why?
|
Confidentiality | 1 | 2017 | 612 | 0.030 |
Why?
|
Risk Factors | 2 | 2018 | 72290 | 0.030 |
Why?
|
Disease Outbreaks | 1 | 2002 | 1772 | 0.030 |
Why?
|
Guideline Adherence | 2 | 2014 | 2266 | 0.030 |
Why?
|
Colon | 1 | 2021 | 1772 | 0.030 |
Why?
|
Genes, Bacterial | 1 | 2016 | 1079 | 0.030 |
Why?
|
Catfishes | 1 | 1992 | 12 | 0.030 |
Why?
|
Psoas Muscles | 1 | 1992 | 71 | 0.030 |
Why?
|
Virus Shedding | 1 | 2012 | 108 | 0.030 |
Why?
|
Guidelines as Topic | 2 | 2011 | 1405 | 0.030 |
Why?
|
Viral Load | 1 | 2021 | 3299 | 0.030 |
Why?
|
Selection, Genetic | 1 | 2016 | 914 | 0.020 |
Why?
|
Vaccines, Attenuated | 1 | 2012 | 342 | 0.020 |
Why?
|
Bites and Stings | 1 | 1992 | 91 | 0.020 |
Why?
|
Random Allocation | 1 | 2015 | 2429 | 0.020 |
Why?
|
Tuberculosis, Pulmonary | 1 | 1977 | 810 | 0.020 |
Why?
|
Aeromonas | 1 | 1990 | 14 | 0.020 |
Why?
|
Time Factors | 2 | 2023 | 40075 | 0.020 |
Why?
|
Bacteria, Aerobic | 1 | 1989 | 25 | 0.020 |
Why?
|
Cost-Benefit Analysis | 2 | 2017 | 5391 | 0.020 |
Why?
|
Serratia marcescens | 1 | 1989 | 45 | 0.020 |
Why?
|
Organizational Policy | 1 | 2012 | 429 | 0.020 |
Why?
|
Adolescent | 7 | 2019 | 85781 | 0.020 |
Why?
|
Oropharynx | 1 | 1989 | 127 | 0.020 |
Why?
|
Pneumonia, Aspiration | 1 | 1989 | 145 | 0.020 |
Why?
|
Enterobacteriaceae | 1 | 1990 | 169 | 0.020 |
Why?
|
Patient Education as Topic | 1 | 2019 | 2278 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2015 | 2715 | 0.020 |
Why?
|
Equipment Contamination | 1 | 1989 | 185 | 0.020 |
Why?
|
Inpatients | 1 | 2020 | 2518 | 0.020 |
Why?
|
Hospital Costs | 1 | 2014 | 985 | 0.020 |
Why?
|
Pneumococcal Infections | 1 | 1992 | 497 | 0.020 |
Why?
|
Foreign Bodies | 1 | 1992 | 399 | 0.020 |
Why?
|
Data Interpretation, Statistical | 1 | 2017 | 2716 | 0.020 |
Why?
|
Immunotherapy | 1 | 2003 | 4445 | 0.020 |
Why?
|
Gastrointestinal Diseases | 1 | 2015 | 1170 | 0.020 |
Why?
|
Epidemiologic Methods | 1 | 2012 | 1364 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2016 | 6171 | 0.020 |
Why?
|
Communicable Diseases, Emerging | 1 | 2008 | 157 | 0.020 |
Why?
|
Terminology as Topic | 1 | 2013 | 1547 | 0.020 |
Why?
|
Mass Chest X-Ray | 1 | 1985 | 16 | 0.020 |
Why?
|
Mortality | 1 | 2017 | 2864 | 0.020 |
Why?
|
Drug Resistance | 1 | 2012 | 1609 | 0.020 |
Why?
|
Histoplasmosis | 1 | 1986 | 66 | 0.020 |
Why?
|
Tetanus | 1 | 1985 | 53 | 0.020 |
Why?
|
Diphtheria | 1 | 1985 | 35 | 0.020 |
Why?
|
Sulfamethoxazole | 2 | 1982 | 53 | 0.020 |
Why?
|
Interprofessional Relations | 1 | 2012 | 1011 | 0.020 |
Why?
|
Rubella | 1 | 1985 | 48 | 0.020 |
Why?
|
Trimethoprim | 2 | 1982 | 91 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2016 | 4803 | 0.020 |
Why?
|
Tuberculin Test | 1 | 1985 | 214 | 0.020 |
Why?
|
Poliomyelitis | 1 | 1985 | 103 | 0.020 |
Why?
|
Incidence | 2 | 2017 | 20947 | 0.020 |
Why?
|
Comorbidity | 1 | 2019 | 10388 | 0.020 |
Why?
|
Arthroplasty, Replacement, Hip | 1 | 2015 | 1462 | 0.020 |
Why?
|
Sentinel Surveillance | 1 | 2006 | 281 | 0.010 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 2015 | 1458 | 0.010 |
Why?
|
Measles | 1 | 1985 | 168 | 0.010 |
Why?
|
Decision Making | 1 | 2017 | 3887 | 0.010 |
Why?
|
Quality Improvement | 1 | 2018 | 3749 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2021 | 19905 | 0.010 |
Why?
|
Reference Standards | 1 | 1985 | 1025 | 0.010 |
Why?
|
Sex Factors | 1 | 2015 | 10397 | 0.010 |
Why?
|
Haemophilus Infections | 1 | 1981 | 95 | 0.010 |
Why?
|
Child, Preschool | 5 | 2019 | 41006 | 0.010 |
Why?
|
Skin Diseases, Infectious | 1 | 1981 | 74 | 0.010 |
Why?
|
Product Surveillance, Postmarketing | 1 | 2005 | 430 | 0.010 |
Why?
|
Haemophilus influenzae | 1 | 1981 | 171 | 0.010 |
Why?
|
Length of Stay | 1 | 2014 | 6309 | 0.010 |
Why?
|
Immunization | 1 | 1985 | 1256 | 0.010 |
Why?
|
Hepatitis | 1 | 2003 | 227 | 0.010 |
Why?
|
Catheterization | 1 | 2006 | 1470 | 0.010 |
Why?
|
Infant | 4 | 2019 | 35136 | 0.010 |
Why?
|
Hepatitis B | 1 | 1985 | 695 | 0.010 |
Why?
|
Cardiac Surgical Procedures | 1 | 2015 | 3537 | 0.010 |
Why?
|
Amikacin | 1 | 1979 | 48 | 0.010 |
Why?
|
Kanamycin | 1 | 1979 | 64 | 0.010 |
Why?
|
Mass Screening | 1 | 2014 | 5255 | 0.010 |
Why?
|
Lung Abscess | 1 | 1978 | 42 | 0.010 |
Why?
|
Drug Eruptions | 1 | 1981 | 297 | 0.010 |
Why?
|
Nocardia | 1 | 1977 | 10 | 0.010 |
Why?
|
Acute Disease | 2 | 1979 | 7149 | 0.010 |
Why?
|
DNA, Bacterial | 1 | 2002 | 1465 | 0.010 |
Why?
|
Herpes Simplex | 1 | 1981 | 470 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2019 | 39050 | 0.010 |
Why?
|
Encephalitis | 1 | 1981 | 423 | 0.010 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 1986 | 2232 | 0.010 |
Why?
|
Streptococcus pyogenes | 1 | 1979 | 289 | 0.010 |
Why?
|
Attitude of Health Personnel | 1 | 2010 | 3843 | 0.010 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2003 | 808 | 0.010 |
Why?
|
Radionuclide Imaging | 1 | 1979 | 2031 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2015 | 25043 | 0.010 |
Why?
|
Syndrome | 1 | 1981 | 3251 | 0.010 |
Why?
|
Blood Glucose | 2 | 2005 | 6256 | 0.010 |
Why?
|
Drainage | 1 | 1978 | 1142 | 0.010 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2003 | 2245 | 0.010 |
Why?
|
Sulfonamides | 1 | 1979 | 1938 | 0.010 |
Why?
|
Wounds, Penetrating | 1 | 1992 | 307 | 0.010 |
Why?
|
Fingers | 1 | 1992 | 513 | 0.010 |
Why?
|
Muscular Diseases | 1 | 1992 | 556 | 0.000 |
Why?
|
Bone and Bones | 1 | 1979 | 2575 | 0.000 |
Why?
|
Postoperative Complications | 1 | 1989 | 15295 | 0.000 |
Why?
|
Chronic Disease | 2 | 1979 | 9146 | 0.000 |
Why?
|
Fractures, Bone | 1 | 1979 | 1947 | 0.000 |
Why?
|
Knee Joint | 1 | 1992 | 1680 | 0.000 |
Why?
|
Opportunistic Infections | 1 | 1986 | 389 | 0.000 |
Why?
|
Counterimmunoelectrophoresis | 1 | 1981 | 15 | 0.000 |
Why?
|
Agglutination Tests | 1 | 1981 | 41 | 0.000 |
Why?
|
Facial Dermatoses | 1 | 1981 | 87 | 0.000 |
Why?
|
Serotyping | 1 | 1981 | 338 | 0.000 |
Why?
|
Nocardia asteroides | 1 | 1979 | 9 | 0.000 |
Why?
|
Vidarabine | 1 | 1981 | 345 | 0.000 |
Why?
|
Pseudomonas fluorescens | 1 | 1978 | 21 | 0.000 |
Why?
|
Acidosis | 1 | 1980 | 270 | 0.000 |
Why?
|
Drug Synergism | 1 | 1982 | 1792 | 0.000 |
Why?
|
Tomography, Emission-Computed | 1 | 1981 | 1144 | 0.000 |
Why?
|
Neck | 1 | 1981 | 697 | 0.000 |
Why?
|
Blood Coagulation Disorders | 1 | 1980 | 337 | 0.000 |
Why?
|
Streptococcus pneumoniae | 1 | 1980 | 714 | 0.000 |
Why?
|
Mice, Inbred BALB C | 1 | 1979 | 6386 | 0.000 |
Why?
|
Lymph Nodes | 1 | 1981 | 3474 | 0.000 |
Why?
|
Escherichia coli | 1 | 1980 | 4217 | 0.000 |
Why?
|
Risk | 1 | 1978 | 9687 | 0.000 |
Why?
|
Animals | 2 | 1992 | 168757 | 0.000 |
Why?
|
Lung | 1 | 1978 | 9856 | 0.000 |
Why?
|
Mice | 1 | 1979 | 81183 | 0.000 |
Why?
|